Unlock instant, AI-driven research and patent intelligence for your innovation.

Biologically Active Peptides

a peptide, biological technology, applied in the field of immunology, can solve the problems of inability to accurately titrate the dosage response function, the exact pharmacological action of the extract cannot be identified, and the active ingredients of the spleen extract cannot be singled ou

Inactive Publication Date: 2007-10-04
PEPHARM R&D LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The peptides, such as those listed in Table A, are found to have significant biological activities in enhancing or inhibiting specific immune functions and can be used to treat conditions like hepatitis, nephritis, and various cancers, providing a safer and more effective alternative to traditional spleen extracts.

Problems solved by technology

However, the molecular composition of such extracts is unknown and therefore the exact pharmacological actions of these extracts cannot be identified.
The dosage response function also cannot be accurately titrated because of the intrinsic heterogeneous nature of these extracts.
Because of such heterogeneity, active ingredients in spleen extracts cannot be singled out and their pharmacological actions cannot be fully utilized.
And, no matter how careful the extraction process can be, there is always the possibility of transmission of diseases of animal origin to human if animal tissue is used as the raw material for extraction.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Delivery of Peptides Through Genetically Engineered Lictobacillus bacterial Species

[0302] The following is provided as one exemplary method to deliver peptides of this invention to a host as described above. A DNA sequence that encodes one of the peptides listed in table A above is synthesized by chemical means and this DNA sequence is inserted into an expression vector using standard techniques of genetic engineering familiar to those skilled in the art. The expression vector selected contains a constitutive promoter functional in Lactobacilli, a multiple cloning site for the introduction of DNA sequences in a specific 5′ to 3′ orientation as well as a selectable marker gene that confers resistance to an antibiotic (to aid in cloning procedures) and may comprise other sequences to assist in the production and / or secretion of the peptides, such as signal peptide sequences. An example of such a vector is provided by U.S. Pat. No. 5,592,908, to Pavla, which is hereby incorporated by...

example 2

Delivery of Peptides Through a Genetically Engineered Form of Bacillus subtilis

[0305] The following is provided as another exemplary method to deliver peptides of this invention to a host as described above. A DNA sequence that encodes one of the peptides listed in table A above is synthesized by chemical means and this DNA sequence is inserted into an expression vector via techniques of genetic engineering, all techniques being known in the art. The expression vector selected comprises a shuttle vector, such as pTZ18R (Pharmacia, Piscataway, N.J.), capable of being propagated in both E. Coli and B. Subtilis and containing an antibiotic resistance gene for selecting colonies of transformed bacteria. This vector can contain a constitutive promoter active in B. subtilis, such as a promoter derived from the Sac B gene of B. subtilis as well as a nucleotide sequence encoding a signal peptide active in B. subtilis that directs efficient export of expressed heterologous proteins from th...

example 3

Delivery of Peptides Through Genetically Engineered Saccharomyces Yeast Species

[0308] The following is provided as another exemplary method to deliver peptides of this invention to a host as described above. A DNA sequence that encodes one of the peptides listed in table A above is synthesized by chemical means and this DNA sequence is inserted into an expression vector via techniques of genetic engineering, all techniques being known in the art. The expression vector selected comprises a stably maintained yeast protein expression vector, comprising a constitutive yeast promoter such as pADH1, sites for replication of the vector in both yeast and E. Coli, a gene or genes that confer prototrophy to an auxotrophic yeast mutant for selection purposes, a multiple cloning site (MCS) and, if desired, sequences that code for a signal peptide. Vectors such as this are commercially available and well known in the art or can be readily constructed using standard techniques After insertion o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
molecular compositionaaaaaaaaaa
intrinsic heterogeneousaaaaaaaaaa
Login to View More

Abstract

Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.

Description

RELATED APPLICATIONS [0001] This patent application is a divisional of copending U.S. patent application Ser. No. 10 / 237,405, filed Sep. 5, 2002, which is a continuation-in-part of U.S. patent application Ser. No. 10 / 178,684, filed Jun. 20, 2002 (abandoned), which is a continuation-in-part of U.S. patent application Ser. No. 09 / 904,492, filed Jul. 13, 2001 (abandoned). The disclosures of all of the above-referenced priority documents are incorporated by reference herein in their entireties.FIELD OF INVENTION [0002] The present invention is related to the field of immunology. In particular, the present invention is directed to peptides and their pharmaceutical compositions which are capable of modulating immune responses. BACKGROUND OF INVENTION [0003] Spleen extracts from mammals have been used successfully for years as medical immune modulators. However, the molecular composition of such extracts is unknown and therefore the exact pharmacological actions of these extracts cannot be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/00C07K5/083C07K5/087C07K5/107C07K5/117C07K7/06C07K7/08C12N1/21
CPCA61K38/00C07K5/0806C07K5/0812C07K7/08C07K5/1024C07K7/06C07K5/1016A61P13/12A61P31/12A61P35/00A61P35/02A61P37/00A61P37/02
Inventor WONG, WAI MINGLAM, KONG
Owner PEPHARM R&D LTD